Mesoblast Ltd (MESO)
11.32
-0.38
(-3.25%)
USD |
NASDAQ |
Nov 14, 16:00
10.50
-0.82
(-7.24%)
After-Hours: 20:00
Mesoblast Total Assets (Quarterly): 669.42M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 669.15M |
| December 31, 2023 | 670.28M |
| June 30, 2023 | 669.42M |
| March 31, 2023 | 650.44M |
| December 31, 2022 | 668.06M |
| September 30, 2022 | 684.50M |
| June 30, 2022 | 662.14M |
| March 31, 2022 | 681.69M |
| December 31, 2021 | 704.44M |
| September 30, 2021 | 721.82M |
| June 30, 2021 | 744.72M |
| March 31, 2021 | 766.12M |
| December 31, 2020 | 687.31M |
| September 30, 2020 | 712.57M |
| June 30, 2020 | 733.60M |
| March 31, 2020 | 665.79M |
| December 31, 2019 | 690.24M |
| September 30, 2019 | 653.79M |
| June 30, 2019 | 652.12M |
| March 31, 2019 | 675.70M |
| December 31, 2018 | 688.33M |
| Date | Value |
|---|---|
| September 30, 2018 | 688.79M |
| June 30, 2018 | 692.44M |
| March 31, 2018 | 677.86M |
| December 31, 2017 | 664.81M |
| September 30, 2017 | 671.90M |
| June 30, 2017 | 655.69M |
| March 31, 2017 | 679.16M |
| December 31, 2016 | 660.88M |
| September 30, 2016 | 665.44M |
| June 30, 2016 | 684.02M |
| March 31, 2016 | 770.14M |
| December 31, 2015 | 790.95M |
| June 30, 2015 | 781.77M |
| December 31, 2014 | 964.58M |
| June 30, 2014 | 899.31M |
| December 31, 2013 | 1.001B |
| December 31, 2013 | 1.001B |
| June 30, 2013 | 883.71M |
| December 31, 2012 | 680.41M |
| June 30, 2012 | 720.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
650.44M
Minimum
Mar 2023
766.12M
Maximum
Mar 2021
693.08M
Average
684.50M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 28.76M |
| Kazia Therapeutics Ltd | 16.61M |
| Immutep Ltd | 32.02M |
| Opthea Ltd | 188.79M |
| Immuron Ltd | 10.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 167.58M |
| Shareholders Equity (Quarterly) | 501.84M |